PTCHD1 and attention deficit-hyperactivity disorder: To assess whether KP metabolites are implicated in pathological conditions of ADHD/ASD, we measured concentrations of KP metabolites following acute ATX treatment in Ptchd1 KO and WT mice at 11 weeks of age.